Satigrel (E5510) is a potent inhibitor of platelet aggregation . Satigrel inhibits collagen- and arachidonic acid-induced platelet aggregation through preventing thromboxane A2 synthesis by selective inhibition of the target enzyme , PGHS1 , which exists in platelets. Satigrel inhibits PGHS1 ( IC 50 : 0.081 μM) and PGHS2 (IC 50 : 5.9 μM). Satigrel is against Type III PDE, Type V and Type II (IC 50 : 15.7 μM, 39.8 μM and 62.4 μM, respectively) .
Specification: ≥99%
Molecular Formula: C20H19NO4
Molecular Weight: 337.4
PubChem CID: 65913
- UPC:
- 51183303
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 1.06 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- S1350936-50mg
- Product Size:
- 50mg
- CAS:
- 111753-73-2